1. |
张海波, 侯晓彤, 郭应强. 心尖途径经导管主动脉瓣置换术围术期管理规范专家建议. 中国胸心血管外科临床杂志, 2023, 30(7): 927-935.Zhang HB, Hou XT, Guo YQ. Expert recommendations for standardized perioperative management after transapical transcatheter aortic valve implantation. Chin J Clin Thorac Cardiovasc Surg, 2023, 30(7): 927-935.
|
2. |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 中国经导管主动脉瓣置换术临床路径专家共识(2021版). 中国介入心脏病学杂志, 2022, 30(1): 7-16.Structural Heart Disease Professional Committee of Cardiovascular Physicians Branch, Chinese Medical Doctor Association. Chinese transcatheter aortic valve replacement clinical pathway expert consensus (2021 edition). Chin J Intervent Cardiol, 2022, 30(1): 7-16.
|
3. |
刘毅, 邓丽, 曹勇, 等. 经导管主动脉瓣膜植入术的临床治疗及应用进展. 心肺血管病杂志, 2021, 40(11): 1175-1178.Liu Y, Deng L, Cao Y, et al. Clinical treatment and application progress of transcatheter aortic valve implantation. J Cardiovasc Pulm Dis, 2021, 40(11): 1175-1178.
|
4. |
周达新, 潘文志, 吴永健, 等. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.Zhou DX, Pan WZ, Wu YJ, et al. Chinese expert consensus on transcatheter aortic valve replacement (2020 update). Chin J Intervent Cardiol, 2020, 28(6): 301-309.
|
5. |
Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: Meta-analysis and systematic review of literature. J Am Coll Cardiol, 2013, 61(15): 1585-1595.
|
6. |
陈思毅, 刘健迪, 刘航宇, 等. 经导管主动脉瓣置换术后发生瓣周漏患者的临床特征及危险因素分析. 中国介入心脏病学杂志, 2023, 31(4): 273-279.Chen SY, Liu JD, Liu HY, et al. Analysis of clinical characteristics and risk factors in patients with paravalvular leakage after transcatheter aortic valve replacement. Chin J Intervent Cardiol, 2023, 31(4): 273-279.
|
7. |
Webb JG, Blanke P, Meier D, et al. TAVI in 2022: Remaining issues and future direction. Arch Cardiovasc Dis, 2022, 115(4): 235-242.
|
8. |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
|
9. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
10. |
Tsoi M, Tandon K, Zimetbaum PJ, et al. Conduction disturbances and permanent pacemaker implantation after transcatheter aortic valve replacement: Predictors and prevention. Cardiol Rev, 2022, 30(4): 179-187.
|
11. |
Zhang X, Liang C, Zha L, et al. Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty™): A retrospective cohort study. BMC Cardiovasc Disord, 2024, 24(1): 77.
|
12. |
Takagi H, Hari Y, Nakashima K, et al. Mortality after transcatheter versus surgical aortic valve replacement: An updated meta-analysis of randomised trials. Neth Heart J, 2020, 28(6): 320-333.
|
13. |
Thonghong T, De Backer O, Søndergaard L. Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. Open Heart, 2018, 5(1): e000753.
|
14. |
Faroux L, Villecourt A, Metz D. The management of coronary artery disease in TAVR patients. J Clin Med, 2023, 12(22): 7126.
|
15. |
Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol, 2019, 74(3): 362-372.
|
16. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
17. |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Kardiol Pol, 2018, 76(12): 1585-1664.
|